A systematic review and meta-analysis of risk factors in the conservative treatment of cesarean scar pregnancy

被引:2
|
作者
Wan, Xiaoli [1 ]
Liao, Yun [1 ]
Hu, Ting [2 ]
Xu, Hongmei [1 ]
Xia, Xiuying [1 ]
Peng, Yu [3 ,4 ]
Wang, Yan [4 ,5 ]
机构
[1] Peoples Hosp Leshan, Dept Obstet & Gynecol, Leshan, Peoples R China
[2] Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Ctr, Dept Gynaecol Oncol,Sichuan Canc Hosp & Inst, Chengdu, Peoples R China
[3] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Acad Journal, Chengdu, Peoples R China
[4] Chinese Acad Sci, Sichuan Translat Med Res Hosp, 32,West Sect 2,First Ring Rd, Chengdu 610072, Peoples R China
[5] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Gynaecol & Obstet, Chengdu, Peoples R China
关键词
Cesarean section; scar pregnancy; conservative treatment; risk factors; meta-analysis; ECTOPIC PREGNANCY; METHOTREXATE; MANAGEMENT; PLACENTA; SECTION;
D O I
10.21037/apm-21-2169
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: It is important to investigate the risk factors of the failure of conservative treatment for cesarean scar pregnancy in order to improve the success rate of treatment and preserve the fertility of patients. This article aims to investigate these factors by meta-analysis, so as to serve as a clinical reference. Methods: PubMed, MEDLINE, Embase, and the Cochrane Library databases were searched. Literatures related to the treatment of cesarean scar pregnancy (CSP) were selected. Literatures were screened according to the inclusion and exclusion criteria, and the quality was evaluated. RevMan 5.3.5 software was used to conduct the meta-analysis on the factors of treatment failure. Results: A total of 7 articles were included in this study, involving 251 patients. Among them, there were 79 (31.5%) cases of conservative treatment failure. The results of the meta-analysis showed that more than 2 cesarean sections [OR =1.79, 95% CI: (0.94, 3.42), P=0.08], mass type CSP [OR =4.06, 95% CI: (2.11, 7.81), P<0.0001], serum beta-hCG value <20,000 U/L [OR =1.81, 95% CI: (0.92, 3.54), P=0.09], and pregnancy time over 3 years from last cesarean section [OR =4.12, 95% CI: (1.29, 13.08), P=0.02] were the risk factors for the failure of conservative treatment of CSP. Discussion: A total of 7 studies were included in this meta-analysis. The results showed that more than 2 cesarean sections, mass type CSP, serum beta-hCG value <20,000 U/L, and pregnancy time over 3 years from last cesarean section were risk factors for the failure of conservative treatment of CSP. Patients with the above risk factors should be screened and informed of the possibility of conservative treatment failure in a timely manner, and different methods should be considered for treatment.
引用
收藏
页码:10434 / 10443
页数:10
相关论文
共 50 条
  • [1] Risk factors for massive hemorrhage during the treatment of cesarean scar pregnancy: a systematic review and meta-analysis
    Zhang, Yuan
    Zhang, Zhongyun
    Liu, Xiaoyan
    Zhang, Lei
    Hong, Fanzhen
    Lu, Ming
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (02) : 321 - 328
  • [2] Risk factors for massive hemorrhage during the treatment of cesarean scar pregnancy: a systematic review and meta-analysis
    Yuan Zhang
    Zhongyun Zhang
    Xiaoyan Liu
    Lei Zhang
    Fanzhen Hong
    Ming Lu
    Archives of Gynecology and Obstetrics, 2021, 303 : 321 - 328
  • [3] Treatments for cesarean scar pregnancy: a systematic review and meta-analysis
    Alameddine, Sara
    Lucidi, Alessandro
    Jurkovic, Davor
    Tritsch, Ilan Timor
    Coutinho, Conrado Milani
    Ranucci, Ludovica
    Buca, Danilo
    Khalil, Asma
    Jauniaux, Eric
    Mappa, Ilenia
    D'Antonio, Francesco
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2024, 37 (01):
  • [4] Evaluation of treatment of previous cesarean scar pregnancy with methotrexate: a systematic review and meta-analysis
    Salari, Nader
    Kazeminia, Mohsen
    Shohaimi, Shamarina
    Nankali, Anis Al-Dawlah
    Mohammadi, Masoud
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2020, 18 (01)
  • [5] Evaluation of treatment of previous cesarean scar pregnancy with methotrexate: a systematic review and meta-analysis
    Nader Salari
    Mohsen Kazeminia
    Shamarina Shohaimi
    Anis al-Dawlah Nankali
    Masoud Mohammadi
    Reproductive Biology and Endocrinology, 18
  • [6] Outcomes of reproduction following cesarean scar pregnancy treatment: A systematic review and meta-analysis
    Wu, Jiawen
    Ye, Jianbin
    OuYang, Zhenbo
    Wana, Zixian
    Zhang, Qiushi
    Zhong, Biting
    Wei, Shiyuan
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 262 : 80 - 92
  • [7] Efficacy and safety of treatment modalities for cesarean scar pregnancy: a systematic review and network meta-analysis
    Fu, Peiying
    Sun, Haiying
    Zhang, Long
    Liu, Ronghua
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2024, 6 (08)
  • [8] Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis
    Cali, G.
    Timor-Tritsch, I. E.
    Palacios-Jaraquemada, J.
    Monteaugudo, A.
    Buca, D.
    Forlani, F.
    Familiari, A.
    Scambia, G.
    Acharya, G.
    D'Antonio, F.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2018, 51 (02) : 169 - +
  • [9] Reproductive outcome after cesarean scar pregnancy: A systematic review and meta-analysis
    Morlando, Maddalena
    Buca, Danilo
    Timor-Tritsch, Ilan
    Cali, Giuseppe
    Palacios-Jaraquemada, Jose
    Monteagudo, Ana
    Khalil, Asma
    Cennamo, Carmen
    La Manna, Viviana
    Liberati, Marco
    D'Amico, Alice
    Nappi, Luigi
    Colacurci, Nicola
    D'Antonio, Francesco
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2020, 99 (10) : 1278 - 1289
  • [10] Conservative treatment of cesarean scar pregnancy with the combination of methotrexate and mifepristone: A systematic review
    Stabile, Guglielmo
    Vona, Laura
    Carlucci, Stefania
    Zullo, Francesco
    Lagana, Antonio Simone
    Etrusco, Andrea
    Restaino, Stefano
    Nappi, Luigi
    WOMENS HEALTH, 2024, 20